Achillion Pharmaceuticals Inc. (ACHN): RA Capital Management Cuts Stake To 19.0% From 21.1%
RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S.
Posts Tagged ‘RA Capital Management’
Cognizant Technology Solutions Corp (CTSH), Titan International Inc. (TWI), Salix Pharmaceuticals Ltd. (SLXP) Among Stocks Hedge Funds Are Bullish On
Amidst the 13F filing season, several hedge funds have also been filing Schedule 13G forms, disclosing changes that took place after June 30, 2014, in their equity positions.
Hedge Fund Highlights: Ken Griffin, Paul Tudor Jones & Bill Ackman
Citadel Investment Group founder Kenneth Griffin yesterday urged Congress not to ban high-frequency trading, but to focus on regulations that would improve market stability.
RA Capital Management Sells 800,000 Shares of Achillion Pharmaceuticals Inc. (ACHN)
RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc.
James Litinsky is Bullish on Ophthotech Corp (OPHT); JHL Capital Boosts Stake in the Company
James H. Litinsky's JHL Capital Group has boosted its stake in Ophthotech Corp (NASDAQ:OPHT) to 1.78 million shares, a new filing with the SEC showed.
RA Capital Reports New 5.8% Position In Recently Public Versartis Inc (VSAR)
Peter Kolchinsky’s RA Capital Management has initiated a new position in Versartis Inc (NASDAQ:VSAR).
Ra Capital Management Reveals New Stake in Enanta Pharmaceuticals Inc (ENTA)
Peter Kolchinsky's Ra Capital Management disclosed a new position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA).
RA Capital Management Discloses New Stake in SANUWAVE Health Inc. (SNWV); Boosts Position in pSivida Corp. (PSDV)
In two recent filings with the U.S. Securities and Exchange Commission, Peter Kolchinsky’s RA Capital Management has revealed a new position in SANUWAVE Health Inc.
RA Capital Discloses New Passive Stake in Repros Therapeutics Inc (RPRX)
RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX).
Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)
Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc.
Ra Capital Management Revealed Stake in Dicerna Pharmaceuticals Inc (DRNA) After Deerfield and Brookside
Ra Capital Management, a fund managed by Peter Kolchinsky, disclosed, in a new filing with the Securities and Exchange Commission, that it owns 2.43 million shares of Dicerna ...
Ra Capital Management Initiates Stake in Furiex Pharmaceuticals Inc (FURX) After the Stock Jumped
Peter Kolchinsky's Ra Capital Management, has just disclosed initiating a 7.2% stake in Furiex Pharmaceuticals Inc (NASDAQ:FURX).
Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)
Kevin C. Tang's Tang Capital Management has decreased its position it two pharmaceutical companies.
Hedge Fund News: Jamie Zimmerman, Perry Capital & Paul Singer
Women hedge fund managers have outperformed their male rivals, on average, for the second year in a row, according to professional services firm Rothstein Kass which tracks the...
Ra Capital Management Lowers Stake in Derma Sciences Inc (DSCI)
Peter Kolchinsky's Ra Capital Management has recently sold a total of 300,000 shares of Derma Sciences Inc (NASDAQ:DSCI).
5 Stocks Hedge Funds Bought Recently
Academic research on hedge funds have shown that the stocks bought by hedge funds outperform the market on average.
Peter Kolchinsky, Ra Capital Buy More Achillion Pharmaceuticals at $2.48/Share
Peter Kolchinsky's, RA Capital Management solidified its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) even more today.
Peter Kolchinsky’s RA Capital Has Been Very Active This Month
Since the beginning of November, Peter Kolchinsky's RA Capital Management has informed the U.S.
This Week’s 6 Most Important Hedge Fund Moves
As we approach the nexus of third quarter 13F filings (next week), hedge funds have been very active in 13D and 13G land.
Ra Capital Boosts Exposure in Dynavax to 9.9%
Peter Kolchinsky's Ra Capital Management surged its position in Dynavax Technologies Corporation (NASDAQ:DVAX) to almost 26 million shares, a new filing with the SEC has revealed...
Peter Kolchinsky’s RA Capital Boosts Stake in Achillion to 21.2%
Peter Kolchinsky and his hedge fund, RA Capital Management, boosted their position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to 21.2%, a filing with the SEC showed.
Peter Kolchinsky, RA Capital Up Stake in Achillion Pharmaceuticals Even Higher
Peter Kolchinsky, Achillion Pharmaceuticals: This afternoon, Peter Kolchinsky and his hedge fund, RA Capital Management, strengthened their position in Achillion Pharmaceuticals...
Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)
Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal the latest moves made by...
Here is What Hedge Funds Think About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
At the moment, there are tons of metrics shareholders can use to monitor their holdings. A couple of the most under-the-radar are hedge fund and insider trading sentiment.
Dyax Corp. (DYAX): Are Hedge Funds Right About This Stock?
Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Here is What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age.
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Do Hedge Funds and Insiders Love Sequenom, Inc. (SQNM)?
If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times.
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
Do Hedge Funds and Insiders Love ArthroCare Corporation (ARTC)?
In the financial world, there are tons of metrics shareholders can use to analyze Mr. Market. A couple of the most innovative are hedge fund and insider trading sentiment.
OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?
To the average investor, there are many gauges shareholders can use to monitor stocks. Two of the most underrated are hedge fund and insider trading movement.
Sangamo Biosciences, Inc. (SGMO): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the 21st century investor’s toolkit, there are a multitude of metrics market participants can use to track stocks.
Hedge Funds Are Crazy About Novavax, Inc. (NVAX)
To most shareholders, hedge funds are viewed as unimportant, old financial vehicles of years past.
Hedge Funds Are Buying ZIOPHARM Oncology Inc. (ZIOP)
In the eyes of most stock holders, hedge funds are seen as underperforming, outdated financial vehicles of years past.
This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)
Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately.
Hedge Funds Are Dumping Cytori Therapeutics Inc. (USA) (CYTX)
In the eyes of most stock holders, hedge funds are perceived as underperforming, old financial tools of the past.
Here is What Hedge Funds Think About Insmed Incorporated (INSM)
Insmed Incorporated (NASDAQ:INSM) was in 11 hedge funds' portfolio at the end of March. INSM shareholders have witnessed an increase in enthusiasm from smart money of late.
Here is What Hedge Funds Think About Senomyx Inc. (SNMX)
To most traders, hedge funds are seen as unimportant, old financial vehicles of the past.
Hedge Funds Are Crazy About Dyax Corp. (DYAX)
In the eyes of most traders, hedge funds are assumed to be worthless, old financial tools of yesteryear.
Derma Sciences Inc (DSCI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
At the moment, there are a multitude of indicators investors can use to watch their holdings. Some of the best are hedge fund and insider trading movement.
Verastem Inc (VSTM): Are Hedge Funds Right About This Stock?
At the moment, there are tons of methods shareholders can use to watch Mr. Market. A pair of the best are hedge fund and insider trading movement.
Should You Avoid Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)?
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor stocks.
Here is What Hedge Funds Think About Dyax Corp. (NASDAQ:DYAX) – QLT Inc. (USA) (NASDAQ:QLTI), Cambrex Corporation (NYSE:CBM)
Is Dyax Corp. (NASDAQ:DYAX) the right investment to pursue these days? The best stock pickers are taking a bullish view.
Hedge Fund News: Dan Loeb, David Einhorn, Ken Griffin
Goldman Sachs Group Inc. (GS), the fifth- biggest U.S. bank by assets, is in talks to sell its hedge-fund administration unit to State Street Corp.
Peter Kolchinsky’s RA Capital Management picked $BEAT
Peter Kolchinsky’s RA Capital Management, LLC initiated a brand new position in CardioNet, Inc. (BEAT).
